期刊文献+

血浆脂蛋白相关性磷脂酶A2活性与颈动脉内中膜厚度的关系 被引量:2

Relationship of lipoprotein-associated phospholipase A2 activity with carotid intima-media thickness
暂未订购
导出
摘要 目的探讨血浆脂蛋白相关性磷脂酶A2(lipoprotein-associated phosphalipase A2,Lp-PLA2)活性与颈动脉内中膜厚度(carotid intima-media thickness,CIMT)关系。方法收集168例患者,依据CIMT将患者分为A组(CIMT>0.9 mm)和B组(CIMT<0.9 mm),检测两组血浆Lp-PLA2活性及其他指标,并分析Lp-PLA2活性及其他指标与CIMT的关系。结果 (1)与B组相比,A组血浆Lp-PLA2活性明显升高,而血浆高密度脂蛋白胆固醇浓度则低于B组,差异有统计学意义(P<0.05);(2)Pearson或Spearman相关分析结果提示吸烟和Lp-PLA2活性与CIMT厚度呈正相关(r=0.665,P=0.168;r=0.815,P=0.001),而高密度脂蛋白胆固醇则与CIMT呈负相关(r=-0.754,P=0.002)。结论对于仅合并吸烟及血浆低高密度脂蛋白胆固醇浓度的患者,其血浆Lp-PLA2活性升高与CIMT呈正相关。 Objectives To investigate the relationship of lipoprotein-associated phospholipase A2 (Lp-PLA2) activity with carotid intima-media thickness (CIMT). Methods Totally 168 patients were enrolled and assigned into two groups according to the values of CIMT (group A, CIMT 〉 0.9 mm; group B, CIMT 〈 0.9 mm). Activity of Lp-PLA2 and values of other variables were evaluated. Relationships of Lp-PLA2 activity and other variables with CIMT were analyzed. Results ( 1 ) Compared to group B, activity of Lp-PLA2 was significantly higher and serum level of high- density lipoprotein cholesterol (HDL-C) was significantly lower in group A (P〈0.05); (2) Pearson or Spearman correlation analysis indicated that smoking and activity of Lp-PLA2 were positively correlated with CIMT (r=0.665, P= 0.168;r=0.815,P=0.001), while serum level of HDL-C was negatively correlated with CIMT (r=-0.754,P=0.002). Conclusions Enhanced activity of Lp-PLA2 in patients barely with smoking and low serum level of HDL-C was positively correlated with CIMT.
出处 《岭南心血管病杂志》 2013年第1期77-79,共3页 South China Journal of Cardiovascular Diseases
关键词 颈动脉内中膜厚度 脂蛋白相关性磷脂酶A2 相关分析 carotid intima-media thickness lipoprotein-associated phospholipase A2 correlation analysis
  • 相关文献

参考文献11

  • 1KINNEY G L, SNELL-BERGEON J K, MAAHS D M,et al.Lipoprotein-associated phospholipase A activity predictsprogression of subclinical coronary atherosclerosis [J]. DiabetesTechnol Ther, 2011,13(3): 381-387.
  • 2TSELEPIS A F, RIZZO M, GOUDEVENOS i A. Therapeuticmodulation of lipoprotein-associated phospholipase A2 (Lp-PLA2)[J]. Curr Pharm Des, 2011, 17(33): 3656-3661.
  • 3IKONOMIDIS I,MICHALAKEAS C A, LEKAKIS J, et al.The role of lipoprotein-associated phospholipase A2 (Lp-PLA)in cardiovascular disease [J]. Rev Recent Clin Trials, 2011, 6(2): 108-113.
  • 4GONG H P, DU Y M, ZHONG L N, et al. Plasma lipoprotein-associated phospholipase A2 in patients with metabolicsyndrome and carotid atherosclerosis[J]. Lipids Health Dis, 2011,10(1): 13.
  • 5KAKKOS S K, TSOLAKIS I A. The emerging role oflipoprotein-associated phospholipase A2 in cerebrovasculardisease[J]. Eur J Vase Endovasc Surg, 2012. 43(2) ; 160.
  • 6VITTOS O, TO ANA B t VITTOS A, et al. Lipoprotein-associated phospholipase A2 (Lp-PLA2) : a review of its roleand significance as a cardiovascular biomarker [ J ]. Biomarkers,2012,17(4): 289-302.
  • 7SANCHEZ-QUESADA J L,VINAGRE I,JUAN-FRANCO E D,et al. Effect of improving glycemic control in patients with type2 diabetes mellitus on low-density lipoprotein size,electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution [J]. Am J Cardiol, 2012,110(1): 67-71.
  • 8GUO Z G, LI C , ZHONG J K, et al. Laboratory investigationof dysfunctional HDL[J]. Chem Phys Lipids,2012,165( 1 ):32-37.
  • 9KLEBER M E,WOLFERT R L, DE MOISSL G D, et al.Lipoprotein associated phospholipase A2 concentration predictstotal and cardiovascular mortality independently of establishedrisk factors (The Ludwigshafen Risk and Cardiovascular HealthStudy) [J]. Clin Lab, 2011,57(9-10): 659-667.
  • 10PAIK J K, KIM J Y, KIM O Y,et al. Circulating and PBMCLp-PLA2 associate differently with oxidative stress andsubclinical inflammation in nonobese women (menopausalstatus) [ J]. Plos One, 2012,7(2) : e296-e275.

同被引文献11

  • 1Guang Ning and Reaction Study Group.Risk Evaluation of cAn- cers in Chinese diabe Tic Individuals:A lONgitudinal (REAC- TION)study. J Diabetes,2012,4:172-173.
  • 2Sigurdardottir V, Fagerberg B, Hulthe J. Preclinical atherosclerosis and inflammation in 61-year-old men with newly diagnosed dia- betes and established diabetes [J]. Diabetes Care,2004,27 (4) : 880-884.
  • 3Lavi S,Herrmann J,Lavi R,et al. Role of lipoprotein-associated phospholipase A2 in atherosclerosis [J]. Curr Atheroscler Rep, 2008,10(3) :230-235.
  • 4Libby P,Ridker PM, Maseri A. Inflammation and atheroselerosis [J].Cireulation, 2002,105 : 1135-1143.
  • 5Koenig W,Twardella D,Brenner H,et al. Lipoprotein- associ- ated phospholipase A2 predicts future cardiovascular events in patients with coronary heart, disease independently of traditional risk factors,markers of inflammation,renal function,and hemo- dynamic stress [J]. Arterioscler Thromb Vasc Biol, 2006,26 (7) : 1586-1593.
  • 6Kolodgie FD,Burke AP,Skorija KS,et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis[J].Arterioscler Thromb Vasc Biol, 2006,26 : 2523-2529.
  • 7华扬,惠品晶,邢瑛琦.中国脑卒中血管超声检查指导规范[J].中华医学超声杂志(电子版),2015,12(8):599-610. 被引量:361
  • 8中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组,彭斌,刘鸣,崔丽英.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682. 被引量:13147
  • 9刘国荣,徐永平,陈伟彬.血浆同型半胱氨酸与颈动脉粥样硬化的相关分析[J].中华老年心脑血管病杂志,2020,22(3):285-287. 被引量:26
  • 10徐昆明,李水彬,成钢卫,曹裕民,赖舒帆.探讨脑梗死患者血清同型半胱氨酸、尿酸水平与颈动脉狭窄程度的关系[J].心血管病防治知识(学术版),2020,10(27):7-9. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部